Prognostic Factors after Pancreatoduodenectomy for Distal Bile Duct Cancer

2011 ◽  
Vol 77 (11) ◽  
pp. 1445-1448 ◽  
Author(s):  
Qi-Lu Qiao ◽  
Tai-Ping Zhang ◽  
Jun-Chao Guo ◽  
Han-Xiang Zhan ◽  
Jian-Xun Zhao ◽  
...  

Prognostic factors influencing long-term survival after radical resection for distal bile duct cancer have not been well established because of the rarity of this malignancy. The goal of this study was to identify main prognostic factors in patients undergoing pancreatoduodenectomy for distal bile duct carcinoma. A retrospective study consisting of 122 patients with distal bile duct cancer who underwent pancreatoduodenectomy in three major university hospitals was performed to identify the main prognostic factors. Major surgical complications occurred in 40 patients (32.8%), of whom eight died (6.6%) in the hospital. Overall actuarial survival (excluding hospital deaths) at 1-, 3-, and 5-year follow-up was 82.9, 49.4, and 32.7 per cent, respectively, with a median survival of 36 months. Univariate analysis showed that papillary tumor ( P = 0.045), negative surgical margin (R0 resection, P = 0.005), earlier pT ( P = 0.005), pTNM stage ( P < 0.001), and absence of lymph node involvement ( P < 0.0001) were significant predictors of survival. On multivariate analysis, only lymph node metastasis was shown to be an independent prognostic factor of survival ( P = 0.036). Lymph node involvement was the most important survival predictor after a Whipple resection in patients with distal cholangiocarcinoma.

Surgery ◽  
2001 ◽  
Vol 129 (6) ◽  
pp. 677-683 ◽  
Author(s):  
Ryoko Sasaki ◽  
Masahiro Takahashi ◽  
Osamu Funato ◽  
Hiroyuki Nitta ◽  
Masahiko Murakami ◽  
...  

2012 ◽  
Vol 10 (1) ◽  
Author(s):  
Takehiro Noji ◽  
Masaki Miyamoto ◽  
Kanako C Kubota ◽  
Toshiya Shinohara ◽  
Yoshiyasu Ambo ◽  
...  

Surgery ◽  
2005 ◽  
Vol 137 (4) ◽  
pp. 396-402 ◽  
Author(s):  
Yoshihiro Sakamoto ◽  
Tomoo Kosuge ◽  
Kazuaki Shimada ◽  
Tsuyoshi Sano ◽  
Hidenori Ojima ◽  
...  

Pancreatology ◽  
2019 ◽  
Vol 19 ◽  
pp. S32-S33
Author(s):  
Christine Tjaden ◽  
Ulf Hinz ◽  
Ulla Klaiber ◽  
Ulrike Heger ◽  
John P. Neoptolemos ◽  
...  

2009 ◽  
Vol 99 (6) ◽  
pp. 335-342 ◽  
Author(s):  
Sae Byeol Choi ◽  
Seung Woo Park ◽  
Kyung Sik Kim ◽  
Jin Sub Choi ◽  
Woo Jung Lee

2013 ◽  
Vol 85 (5) ◽  
pp. 212 ◽  
Author(s):  
Young Jae Chung ◽  
Dong Wook Choi ◽  
Seong Ho Choi ◽  
Jin Seok Heo ◽  
Dong Hun Kim

Author(s):  
Samantha Taber ◽  
Joachim Pfannschmidt ◽  
Torsten T. Bauer ◽  
Torsten G. Blum ◽  
Christian Grah ◽  
...  

Abstract Background In patients with non-small cell lung cancer (NSCLC), the pathologic union for international cancer control (UICC) stage IIIA is a heterogeneous entity, with different forms of N2-lymph node involvement representing different prognoses. Although a multimodality treatment approach, including surgery, systemic therapy, and/or radiotherapy, is almost always recommended, in this retrospective observational study, we sought to determine whether long-term survival might be possible in selected patients who are treated with complete surgical resection alone. Methods Between 2013 and 2018, we retrospectively identified 24 patients with NSCLC (16 men and 8 women), who were found to have pathologic N2-lymph node involvement, and were treated with complete surgical lung resection and systematic mediastinal and hilar lymph node dissection but no neoadjuvant or adjuvant treatment. Results The most frequent reason (n = 14) for forgoing adjuvant treatment was patient refusal. The mean overall survival (OS) was 34.5 months (interquartile range [IQR]: 15.5–53.5 months). The mean disease-free survival (DFS) was 18 months (IQR: 4.75–46.75 months). We identified five patients who survived at least 5 years without recurrence (21%). In each of these cases, the nodal metastases were restricted to a single level and no extracapsular lymph node involvement were detected. Additionally, worse DFS was associated with pT3/4 (vs. a lower T-stage), as well as microscopic lymphovascular invasion. Conclusion Although the small sample size precludes any definitive conclusions, it was possible to demonstrate that long-term survival without neoadjuvant and adjuvant treatment is possible in some patients if complete tumor and nodal resection is performed.


Sign in / Sign up

Export Citation Format

Share Document